MOSAX
Price
$9.67
Change
+$0.05 (+0.52%)
Updated
Jul 9 closing price
Net Assets
397.11M
VDVIX
Price
$14.25
Change
+$0.09 (+0.64%)
Updated
Jul 9 closing price
Net Assets
232.17B
Interact to see
Advertisement

MOSAX vs VDVIX

Header iconMOSAX vs VDVIX Comparison
Open Charts MOSAX vs VDVIXBanner chart's image
MassMutual Overseas A
Price$9.67
Change+$0.05 (+0.52%)
VolumeN/A
Net Assets397.11M
Vanguard Developed Markets Index I
Price$14.25
Change+$0.09 (+0.64%)
VolumeN/A
Net Assets232.17B
MOSAX vs VDVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MOSAX vs. VDVIX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MOSAX is a Buy and VDVIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VDVIX has more cash in the bank: 232B vs. MOSAX (397M). VDVIX pays higher dividends than MOSAX: VDVIX (2.60) vs MOSAX (1.11). MOSAX was incepted earlier than VDVIX: MOSAX (24 years) vs VDVIX (12 years). MOSAX (1.42) is less costly to investors than VDVIX (0.16). MOSAX is a more actively managed with annual turnover of: 21.00 vs. VDVIX (3.00). VDVIX has a lower initial minimum investment than MOSAX: VDVIX (0) vs MOSAX (1000). VDVIX annual gain was more profitable for investors over the last year : 14.17 vs. MOSAX (11.33). VDVIX return over 5 years is better than : 47.17 vs. MOSAX (31.27).
MOSAXVDVIXMOSAX / VDVIX
Total Expense Ratio1.290.16806%
Annual Report Gross Expense Ratio1.420.16888%
Fund Existence24 years12 years-
Gain YTD19.20719.279100%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets397M232B0%
Annual Yield % from dividends1.112.6043%
Returns for 1 year11.3314.1780%
Returns for 3 years31.2241.9175%
Returns for 5 years31.2747.1766%
Returns for 10 years26.2150.6152%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XTLB1.600.37
+30.08%
XTL Biopharmaceuticals Ltd
OR26.620.81
+3.14%
OR Royalties Inc.
UWMC4.260.11
+2.65%
UWM Holdings Corp
COO74.950.69
+0.93%
Cooper Companies (The)
OFS8.46-0.18
-2.08%
OFS Capital Corp